# Acumen Pharmaceuticals, Inc. (ABOS)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/ABOS/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -53.46M | $ -42.20M | $ 31.57M | $ 57.26M |
| 2025 | $ 0 | $ -124.24M | $ -118.39M | $ 31.31M | $ 70.43M |
| 2024 | $ 0 | $ -107.56M | $ -90.64M | $ 29.70M | $ 181.82M |
| 2023 | $ 0 | $ -56.63M | $ -46.59M | $ 28.49M | $ 266.97M |
| 2022 | $ 0 | $ -47.87M | $ -39.45M | $ 105.0K | $ 188.78M |
| 2021 | $ 0 | $ -119.59M | $ -21.40M | $ 0 | $ 225.18M |
| 2020 | $ 1.83M | $ -9.33M | $ -9.49M | $ 0 | $ -18.59M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.55 |
| Liabilities / Eq | 1.03 |
| Current Ratio | 2.47 |

## Other views

- [Metrics](https://sponda.capital/en/ABOS.md)
- [Charts](https://sponda.capital/en/ABOS/charts.md)
- [Compare](https://sponda.capital/en/ABOS/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.